Cargando…
The Mechanism of Bisdemethoxycurcumin Enhances Conventional Antibiotics against Methicillin-Resistant Staphylococcus aureus
Methicillin-resistant Staphylococcus aureus (MRSA) infection has posed a serious threat to public health, therefore, the development of new antibacterial drugs is imperative. Bisdemethoxycurcumin (BDMC) is a curcumin analog that exists in nature and possesses extensive pharmacological actions. This...
Autores principales: | Wang, Shu, Kim, Min-Chul, Kang, Ok-Hwa, Kwon, Dong-Yeul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662602/ https://www.ncbi.nlm.nih.gov/pubmed/33114703 http://dx.doi.org/10.3390/ijms21217945 |
Ejemplares similares
-
Bisdemethoxycurcumin Reduces Methicillin-Resistant Staphylococcus aureus Expression of Virulence-Related Exoproteins and Inhibits the Biofilm Formation
por: Wang, Shu, et al.
Publicado: (2021) -
Trans-Cinnamaldehyde Exhibits Synergy with Conventional Antibiotic against Methicillin-Resistant Staphylococcus aureus
por: Wang, Shu, et al.
Publicado: (2021) -
Synergistic Antibacterial Activity with Conventional Antibiotics and Mechanism of Action of Shikonin against Methicillin-Resistant Staphylococcus aureus
por: Li, Qian-Qian, et al.
Publicado: (2022) -
Combination of Sanguisorbigenin and Conventional Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus: Inhibition of Biofilm Formation and Alteration of Cell Membrane Permeability
por: Wang, Shu, et al.
Publicado: (2022) -
Curcumin Reverse Methicillin Resistance in Staphylococcus aureus
por: Mun, Su-Hyun, et al.
Publicado: (2014)